Charles Schwab Investment Management Inc Guardant Health, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,013,272 shares of GH stock, worth $71.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,013,272
Previous 996,506 1.68%
Holding current value
$71.1 Million
Previous $42.5 Million 24.21%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$37.05 - $52.04 $621,180 - $872,502
16,766 Added 1.68%
1,013,272 $52.7 Million
Q1 2025

Sep 15, 2025
SELL
$31.77 - $49.94 $532,655 - $837,294
-16,766 Reduced 1.65%
996,506 $42.5 Million
Q1 2025

May 09, 2025
SELL
$31.77 - $49.94 $636,257 - $1 Million
-20,027 Reduced 1.97%
996,506 $42.5 Million
Q4 2024

Feb 06, 2025
BUY
$20.2 - $38.11 $270,579 - $510,483
13,395 Added 1.34%
1,016,533 $31.1 Million
Q3 2024

Nov 12, 2024
SELL
$22.3 - $36.29 $6.83 Million - $11.1 Million
-306,293 Reduced 23.39%
1,003,138 $23 Million
Q2 2024

Aug 12, 2024
BUY
$16.07 - $31.84 $519,575 - $1.03 Million
32,332 Added 2.53%
1,309,431 $37.8 Million
Q1 2024

May 08, 2024
BUY
$17.13 - $26.91 $770,541 - $1.21 Million
44,982 Added 3.65%
1,277,099 $26.3 Million
Q4 2023

Feb 06, 2024
BUY
$21.58 - $29.5 $444,936 - $608,231
20,618 Added 1.7%
1,232,117 $33.3 Million
Q3 2023

Nov 08, 2023
BUY
$25.8 - $39.97 $7.56 Million - $11.7 Million
292,888 Added 31.88%
1,211,499 $35.9 Million
Q2 2023

Aug 09, 2023
BUY
$20.94 - $38.01 $6.55 Million - $11.9 Million
312,875 Added 51.65%
918,611 $32.9 Million
Q1 2023

May 11, 2023
BUY
$22.92 - $33.76 $120,421 - $177,375
5,254 Added 0.87%
605,736 $14.2 Million
Q4 2022

Feb 13, 2023
BUY
$25.44 - $59.78 $603,258 - $1.42 Million
23,713 Added 4.11%
600,482 $16.3 Million
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $352,947 - $493,124
8,084 Added 1.42%
576,769 $31 Million
Q2 2022

Aug 15, 2022
BUY
$28.82 - $77.35 $335,810 - $901,282
11,652 Added 2.09%
568,685 $22.9 Million
Q1 2022

May 13, 2022
BUY
$48.25 - $100.49 $607,950 - $1.27 Million
12,600 Added 2.31%
557,033 $36.9 Million
Q4 2021

Feb 11, 2022
BUY
$88.71 - $120.43 $1.19 Million - $1.62 Million
13,450 Added 2.53%
544,433 $54.5 Million
Q3 2021

Nov 16, 2021
BUY
$98.77 - $132.17 $9.22 Million - $12.3 Million
93,306 Added 21.32%
530,983 $66.4 Million
Q2 2021

Aug 16, 2021
BUY
$109.77 - $165.68 $1.57 Million - $2.37 Million
14,293 Added 3.38%
437,677 $54.4 Million
Q1 2021

May 17, 2021
BUY
$127.04 - $179.1 $339,450 - $478,555
2,672 Added 0.64%
423,384 $64.6 Million
Q4 2020

Feb 16, 2021
BUY
$99.96 - $135.93 $4.09 Million - $5.57 Million
40,959 Added 10.79%
420,712 $54.2 Million
Q3 2020

Nov 13, 2020
BUY
$80.32 - $111.8 $10.1 Million - $14 Million
125,620 Added 49.43%
379,753 $42.4 Million
Q2 2020

Aug 14, 2020
BUY
$60.49 - $97.5 $3.76 Million - $6.06 Million
62,145 Added 32.37%
254,133 $20.6 Million
Q1 2020

May 15, 2020
BUY
$59.04 - $88.81 $1.06 Million - $1.6 Million
17,998 Added 10.34%
191,988 $13.4 Million
Q4 2019

Feb 07, 2020
BUY
$59.49 - $82.78 $229,036 - $318,703
3,850 Added 2.26%
173,990 $13.6 Million
Q3 2019

Nov 08, 2019
BUY
$62.59 - $110.3 $1.52 Million - $2.67 Million
24,214 Added 16.59%
170,140 $10.9 Million
Q2 2019

Aug 09, 2019
BUY
$63.94 - $91.11 $4.44 Million - $6.32 Million
69,363 Added 90.6%
145,926 $12.6 Million
Q1 2019

May 14, 2019
BUY
$34.3 - $97.98 $84,549 - $241,520
2,465 Added 3.33%
76,563 $5.87 Million
Q4 2018

Feb 14, 2019
BUY
$29.2 - $46.1 $2.16 Million - $3.42 Million
74,098 New
74,098 $2.79 Million

Others Institutions Holding GH

# of Institutions
419
Shares Held
126M
Call Options Held
1.51M
Put Options Held
2.35M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $7.18B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email